Literature DB >> 15847314

Causes of blindness and the results of cataract surgical intervention in the Micronesian islands: a retrospective study.

Narumichi Yamamoto1, Yasuo Sugata, Kimio Murakami, Yukio Yamamoto.   

Abstract

Since 1983, we have delivered eye care to inhabitants of the Micronesia islands a total of 18 times over an 18-year period. Approximately 14,000 islanders were examined. We diagnosed a total of 1226 blind eyes and 1231 eyes with low vision. Unoperated cataract (n = 765, 62.4%) was the leading cause of blindness in our data, and 611 cataract operations were performed. The preoperative visual acuity of the patients who underwent cataract surgery was less than 20/200. Visual acuity improved in 588 cases (96.2%) after the surgery. Sight-threatening complications occurred in 1.1% (7) of the eyes after the surgery, which is comparable to the rate in developed countries. Corneal opacity secondary to infection (11.2%) was the second leading cause of blindness in our data. Diabetic retinopathy (9.9%) was a cause of low vision in our data, and the number of eyes diagnosed with diabetic retinopathy in each district increased over the years. Glaucoma was the cause of blindness in 1.9% of the blind eyes, although the percentage may actually have been higher because visual loss was assessed only by reduced visual acuity. The demand for correcting refractive errors that caused a visual acuity of less than 20/60, was evident throughout the region. The majority of blind individuals in this study were suffering from operable cataract and good results were obtained with cataract surgery in this region. Further training of local medical staff would significantly improve eye care services in Micronesia.

Entities:  

Mesh:

Year:  2004        PMID: 15847314     DOI: 10.1007/s10792-004-5196-1

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  14 in total

1.  Human evolution. Diabetes running wild.

Authors:  J M Diamond
Journal:  Nature       Date:  1992-06-04       Impact factor: 49.962

2.  Development, advantages, and methods of the continuous circular capsulorhexis technique.

Authors:  H V Gimbel; T Neuhann
Journal:  J Cataract Refract Surg       Date:  1990-01       Impact factor: 3.351

3.  Cataract surgery. A global perspective.

Authors:  H R Taylor; A Sommer
Journal:  Arch Ophthalmol       Date:  1990-06

4.  National survey of blindness and low vision in The Gambia: results.

Authors:  H Faal; D Minassian; S Sowa; A Foster
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

5.  Analysis of capsular bag defects and intraocular lens positions for consistent centration.

Authors:  J A Davison
Journal:  J Cataract Refract Surg       Date:  1986-03       Impact factor: 3.351

6.  Factors associated with the development of diabetes in the Micronesian population of Nauru.

Authors:  B Balkau; H King; P Zimmet; L R Raper
Journal:  Am J Epidemiol       Date:  1985-10       Impact factor: 4.897

7.  Normal coding sequence of insulin gene in Pima Indians and Nauruans, two groups with highest prevalence of type II diabetes.

Authors:  N Raben; F Barbetti; A Cama; M A Lesniak; S Lillioja; P Zimmet; S W Serjeantson; S I Taylor; J Roth
Journal:  Diabetes       Date:  1991-01       Impact factor: 9.461

8.  Sunlight and other risk factors for cataracts: an epidemiologic study.

Authors:  G W Collman; D L Shore; C M Shy; H Checkoway; A S Luria
Journal:  Am J Public Health       Date:  1988-11       Impact factor: 9.308

9.  Visual outcome and complications after cataract extraction in Saudi Arabia.

Authors:  M F al Faran
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

10.  Blindness in Saudi Arabia.

Authors:  K F Tabbara; D Ross-Degnan
Journal:  JAMA       Date:  1986-06-27       Impact factor: 56.272

View more
  1 in total

1.  A systematic review of historical and contemporary evidence of trachoma endemicity in the Pacific Islands.

Authors:  Becca L Handley; Chrissy H Roberts; Robert Butcher
Journal:  PLoS One       Date:  2018-11-15       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.